Home » Newsletters » BioWorld Science

BioWorld Science

April 15, 1998

View Archived Issues

Fuisz receives notice of issuance for interferon patch patent

Beckman Coulter and Immunomedics agree to form new company

Structure and biological activity of UCH9, a novel antitumor antibiotic

CombiChem achieves milestone in collaboration with Roche Bioscience

Cel-Sci introduces L.E.A.P.S. technology at scientific conference

AAT clinical trials update from PPL Therapeutics

Pfizer presents new inhibitors of MMPs and/or TNF production

Novartis establishes functional genomics research institute

Rhone-Poulenc Rorer awards seven research grants to Stanford University investigators

Neurogen evaluates benzylamine derivatives as NPY receptor ligands

Ibex Technologies initiates phase III testing of Neutralase

Therapeutic Antibodies: year-end 1997 highlights

TP10 improves outcome in open heart surgery model

Bristol-Myers Squibb and Acacia Biosciences sign drug discovery agreement

Bio-Technology General signs U.S. marketing agreement with Akorn for BioLon

American Biogenetics Sciences expands Europe distribution of TpP test

Nycomed Amersham: nine-month highlights

Anticonvulsant drugs: a new treatment alternative for psychiatric disorders

Kappa agonists developed at Warner-Lambert

MMP inhibitors particularly active against MMP-13 described by Monsanto

Yamanouchi describes novel antidiabetic agents

Water-soluble taxane derivatives under evaluation at Yakult Honsha

Antiviral drugs advisory committee will discuss Intron A/Rebetol NDA

Antiviral drugs advisory committee will discuss Priftin NDA

Antiviral drugs advisory committee will discuss NTZ NDA

AnorMED licenses platinum anticancer agent to Zeneca

New agent for prevention of HCV in development at Nabi

Aquila Biopharmaceuticals acquires VacTex

Leading Hungarian pharmaceutical company acquired by U.S. investors